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Abstract: The percentage of the population described as elderly is growing, and a higher 
prevalence of multiple, chronic disease states must be managed concurrently. Healthcare prac-
titioners must appropriately use medication for multiple diseases and avoid risks often associ-
ated with multiple medication use such as adverse effects, drug/drug interactions, drug/disease 
interactions, and inappropriate dosing. The purpose of this study is to identify a consensus 
deﬁ  nition for polypharmacy and evaluate its prevalence among elderly outpatients. The authors 
also sought to identify or develop a clinical tool which would assist healthcare practitioners 
guard against inappropriate drug therapy in elderly patients. The most commonly cited deﬁ  ni-
tion was a medication not matching a diagnosis. Inappropriate was part of deﬁ  nitions used 
frequently. Some deﬁ  nitions placed a numeric value on concurrent medications. Two common 
deﬁ  nitions (ie, 6 or more medications or a potentially inappropriate medication) were used to 
evaluate polypharmacy in elderly South Carolinians (n = 1027). Data analysis demonstrates 
that a signiﬁ  cant percentage of this population is prescribed six or more concomitant drugs 
and/or uses a potentially inappropriate medication. The ﬁ  ndings are 29.4% are prescribed 6 or 
more concurrent drugs, 15.7% are prescribed one or more potentially inappropriate drugs, and 
9.3% meet both deﬁ  nitions of polypharmacy used in this study. The authors recommend use 
of less ambiguous terminology such as hyperpharmacotherapy or multiple medication use. A 
structured approach to identify and manage inappropriate polypharmacy is suggested and a 
clinical tool is provided.
Keywords: hyperpharmacotherapy, polypharmacy, geriatrics, inappropriate medication, 
inappropriate pharmacy, multiple medication use
Background
The use of multiple medications, often termed polypharmacy, is recognized as an 
increasingly serious problem in the current healthcare system. The US General 
Accounting Ofﬁ  ce reports signiﬁ  cant morbidity and mortality associated with inap-
propriate polypharmacy. In addition, polypharmacy is recognized as an expensive prac-
tice: the US Center for Medicare and Medicaid Services estimates that polypharmacy 
costs its nation’s health plans more than US$50 billion annually (Berenbeim 2002). 
But the issue of multiple medication use, particularly by elderly patients, is a complex 
one. The potential risks of polypharmacy are evident; however, so are the beneﬁ  ts to 
patients when medication therapies are combined to  cure, slow the progression, or 
reduce the symptoms of disease. Additionally, a plethora of drug therapies for chronic 
disease can improve quality of life and prevent complications, including disability and 
unnecessary hospitalization. Balancing the risks and beneﬁ  ts of multiple drug therapies 
in older adults becomes a challenging endeavor for prescribers. Education and strate-
gies which enable the healthcare practitioner to achieve successful polypharmacy and 
avoid inappropriate polypharmacy must be developed and shared.
Patients 65-years-old and older are the largest consumers of prescription and 
nonprescription medications in the US, and the use of prescription and nonprescrip-
tion medications among this group has more than doubled since 1990 and continues Clinical Interventions in Aging 2008:3(2) 384
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to rise, according to the Centers for Disease Control and 
Prevention (CDC). Elderly Americans consume one-third 
of all the prescription medications prescribed each year, yet 
they comprise less than 13% of the population (Azad 2005; 
CDC 2005). The relatively high rates of drug consumption by 
elderly patients and numerous other factors contribute to the 
increased prevalence of medication-associated morbidity and 
mortality affecting this population. Signiﬁ  cant contributing 
factors are the physiologic changes associated with aging, 
which may include decreased renal elimination, decreased 
hepatic function, decreased total body water and lean body 
mass, and age-related declines in vision and hearing. Several 
of these changes can lead to alterations in the pharmacokinet-
ics of medications for many elderly patients, namely altered 
distribution, metabolism, and elimination. Other contributing 
factors are pathophysiologic alterations involved with dis-
ease, frequency of chronic disease and medical comorbidities, 
communication barriers, and healthcare delivery involving 
multiple prescribers (GAO 2000; Delafuente 2003).
Purpose
Because individuals are living longer and accruing chronic 
diseases, practitioners have a new responsibility to prescribe 
appropriately the many medications available to manage 
concurrent disease states. The plethora of pharmaceutical 
options must be balanced with the potential risk of multiple 
medication use. These risks include, but are not limited to, 
adverse effects, drug/drug interactions, drug/disease interac-
tions and inappropriate dosing regimens. Primary care health 
professionals such as physicians, physician assistants, and 
nurses have an enormous opportunity to survey patients for 
this risk given their accessibility and roles in the coordination 
of care. Nearly 45% of physician assistants, for example, 
practice in family medicine, general internal medicine, or 
internal medicine subspecialties, according to the American 
Academy of Physician Assistants Census Report (AAPA 
2006). These providers and others have an opportunity to 
ensure appropriate medication management, especially in 
their elderly patients. Originally, the purpose of this study 
was to identify the consensus deﬁ  nition for polypharmacy 
and evaluate its prevalence within elderly outpatients in the 
state of South Carolina. A review of the literature, however, 
revealed that no consensus existed in the medical literature 
on the deﬁ  nition for polypharmacy. Thus, it became neces-
sary to evaluate and clarify terminology currently used in 
the medical literature to describe multiple medication use in 
the older adult before evaluating the prevalence of polyphar-
macy. Additionally, the authors sought to identify or develop 
a clinical tool to assist healthcare practitioners guard against 
inappropriate drug therapy in elderly patients.
Methods
In the ﬁ  rst phase of this study, a literature review was con-
ducted within OVID for original articles published between 
January 1997 and May 2007, using the following search 
terms and phrases: ‘polypharmacy,’ ‘elderly,’ ‘geriatrics,’ 
‘inappropriate medication,’ and ‘multiple medication use.’ 
English language articles available in local holding which 
described ‘polypharmacy’ or the issue of the simultaneous 
use of multiple medications in elderly patients were evalu-
ated. Discrete deﬁ  nitions of polypharmacy were identiﬁ  ed 
and recorded.
Throughout the literature, numerous articles used the 
term ‘polypharmacy’ and the phrase ‘inappropriate drug use’ 
interchangeably. The research reported that methods most 
often used for identifying inappropriate drug use involved 
the use of criteria, primarily the criteria developed, and more 
recently revised, by Beers and colleagues (Beers 1997; Fick 
et al 2003). The investigators adapted a list of inappropriate 
drugs from two primary sources for use in this study (Fick 
et al 2003; Bressler and Bahl 2003). The medications used 
in this research were based upon the Beers’ criteria but 
were limited to those identiﬁ  ed as “high risk” (see Table 2). 
This list is labeled as ‘potentially inappropriate,’ because 
we recognize that use of one or more of these agents in an 
older adult could be justiﬁ  ed by speciﬁ  c circumstances, for 
example, if safer alternatives had been exhausted.
Two different deﬁ  nitions of polypharmacy were applied 
to the database, which consisted of outpatient medical record 
data randomly collected by physician assistant students at the 
time of patient encounters during supervised clinical training 
from August 2006 to May 2007. Polypharmacy was deﬁ  ned 
as either “use of at least one potentially inappropriate drug” 
(see Table 2) or “the presence of six or more concurrent 
medications”. The database included patient demographics 
(ie, age, gender, ethnicity, educational level, and marital 
status), vital signs, diagnoses, prescription medications, 
health-related quality of life, and disease-speciﬁ  c markers 
when applicable (ie, blood pressure, urine microalbumin, 
hemoglobin A1c, creatinine clearance, liver transaminases, 
estimated left ventricular ejection fraction, and others). These 
outpatient data were collected from more than 500 outpatient 
clinical sites throughout the state of South Carolina repre-
senting the following disciplines: family medicine, general 
internal medicine, pediatrics, general surgery, gynecology 
and obstetrics, emergency medicine, and internal medicine Clinical Interventions in Aging 2008:3(2) 385
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subspecialties. At the time of analysis the database contained 
10,455 discrete patient entries, and the 1270 entries involving 
patients 65-years or older were selected for investigation.
Results
The term ‘polypharmacy’ is frequently used in the medical 
literature; however, the deﬁ  nitions of polypharmacy often 
varied from scholar to scholar. No consensus deﬁ  nition for 
polypharmacy was readily identiﬁ  ed. The various deﬁ  nitions 
of polypharmacy identiﬁ  ed in 11 publications reviewed are 
summarized in Table 1. The most commonly cited deﬁ  ni-
tion, which appeared in four articles, “was medication did 
not match diagnosis”. The term ‘inappropriate’ was part 
of deﬁ  nitions used in six articles. Several other different 
deﬁ  nitions, used by at least three scholars, involved one of 
the following concepts: many medications, duplication of 
Table 1 Deﬁ  nitions of polypharmacy
Speciﬁ  c deﬁ  nitions of polypharmacy 
(Polypharmacy is…)
Number 
of articles
Other descriptions of inappropriate 
medication use
Number 
of articles
Medication does not match the diagnosis* 45, 9, 16, 22 Drug/drug interactions 32, 10, 22
Many medications 310, 14, 22 Excessive duration 32, 10, 22
Duplication of medication* 35, 9, 16 Inappropriate drugs (ie, lack of proven beneﬁ  t, 
drug indication, etc.)
22, 10
Drug/drug interactions* 29, 16 Drugs that cause adverse effects 210, 22
Inappropriate dosing frequency (excessive, too low, 
too long)*
25, 16 Drug/disease interactions 22, 22
Medication prescribed to treat the side effect
of another medication (except for cases where there 
is no other option)*
25, 16 Availability of an equally effective, lower-cost 
alternative
22, 22
Two or more drugs of the same chemical class 18 Excessive dosages 22, 10
Two or more meds to treat the same condition 18 Inappropriate dosing frequency 22, 10
(excessive, too low, too long)
Two or more agents with the same or similar 
pharmacologic actions to treat different conditions
18 Complicated drug regimen affecting compliance 22, 10
Minor polypharmacy = 2–4 meds. Major 
polypharmacy 5 meds.
120 Prescription of multiple meds by different specialists 
for treating concurrent conditions
12
3,5, or 6 different medications 117 Medication does not match the diagnosis 122
Two or more medications 118 Medication prescribed to treat the side effect
of another medication (except for cases where 
there is no other option)
122
Greater than 5 medications 15 Polypills 122
Excessive use of medication 116 More than one pharmacy used 122
Unnecessary use of medication 116 Multiple prescribers of medication 122
Medications prescribed greater than twice per day 15 High risk medications 122
Complicated drug regimen effecting compliance* 19 Number of medications 122
Contraindicated in the elderly 19 Diet 122
Taking an OTC medication, an herbal product or 
another person’s medication
19 Frequency of medication therapy monitoring 122
Availability of an equally effective, lower-cost 
alternative*
15 Male Gender 122
Patient misunderstanding of the use of the 
medication (purpose, how to take it, side effects 
possible, toxicity signs, etc)
15 New resident to nursing home 122
Dosage does not reﬂ  ect age/renal/liver status 15 Medication is not the most effective available 122
Improvement after discontinuation of medications 116 Treatment goals unmet 12
Diagnosis no longer present 15 Duplication of medication 12
*Also a description of multiple medication use.Clinical Interventions in Aging 2008:3(2) 386
Bushardt et al
medications, drug/drug interactions, and excessive dura-
tion. Some deﬁ  nitions for polypharmacy place a value on 
the number of concurrent medications; the most commonly 
referenced number was six medications or more. This ﬁ  nding 
is interesting especially because elderly residents of extended 
care facilities typically receive more than seven medications 
per day (Chutka et al 2004).
Because no consensus definition for polypharmacy 
emerged during our literature review, we applied two of the 
most commonly cited ones to our dataset, speciﬁ  cally “use 
of a potentially inappropriate drug” or “use of six or more 
concomitant drugs”. The analyses of the data collected from 
elderly patients demonstrate that a signiﬁ  cant percentage of 
this population are, in fact, prescribed six or more concomitant 
drugs and/or use a potentially inappropriate medication. Of 
the 1270 elderly patients evaluated, 29.4% are prescribed 6 or 
more concurrent drugs, 15.7%, or 199 patients, are prescribed 
one or more potentially inappropriate drugs, and 9.3% meet 
both deﬁ  nitions of polypharmacy used in this study (ie, “six 
or more concurrent medications” and “at least one potentially 
inappropriate drug”). The potentially inappropriate medica-
tions prescribed include medications known to produce sig-
niﬁ  cant central nervous system depressant or anti-cholinergic 
effects. For example, 32% of the patients who were prescribed 
a potentially inappropriate drug received at least one benzo-
diazepine-containing products (see Table 2).
Discussion
Poly, of Greek origin, is simply deﬁ  ned by Webster as “many, 
several, much, multi, containing an indefinite number.” 
Attaching this preﬁ  x to the word ‘pharmacy’ implies many 
pharmacies, and is devoid of any moral value. The results 
presented in Table 1 clearly demonstrate the lack of consis-
tency with the use of the term ‘polypharmacy’ in the medical 
literature. To further complicate the issue, the term ‘polyphar-
macy’ connotes a negative, inappropriate medication use in 
some areas of the literature, but in other publications, the term 
describes an appropriate combination of multiple medications. 
In other words, one word, polypharmacy, can be both negative 
and positive. This duality makes objective research difﬁ  cult, 
to say the least. Of the 11 articles that describe polypharmacy, 
24 distinctly different deﬁ  nitions emerge. The most common 
deﬁ  nition identiﬁ  ed, “medication does not meet diagnosis,” is 
clearly synonymous with unnecessary or inappropriate. Many 
of the deﬁ  nitions identiﬁ  ed were also quite vague, complicat-
ing any attempt to quantify or study further the issue through 
standardized, measureable methodologies. For example, the 
description, “excessive use,” can be interpreted in many ways. 
Excessive might refer to the frequency of the drug, the dosage, 
unintentional overuse, intentional misuse or abuse, or drug 
consumption when a nondrug alternative is more appropriate. 
The lack of objective terminology and precision in deﬁ  nition 
is replicated in the multiple interpretations of the descriptions, 
“many medications,” “unnecessary use,” and “duplication of 
medication”. Arguably, prescribing a single medication that 
does not match a diagnosis would be considered inappropriate 
polypharmacy. A quantity-speciﬁ  c deﬁ  nition of polyphar-
macy, however, is easy to construct and apply, but this method 
is associated with a relatively high rate of false positives, not 
speciﬁ  c for ‘inappropriate medication use.’ The vague and 
often dissimilar use of the term ‘polypharmacy’ within the 
literature supports the discontinuation of its use.
Table 2 Percentage of patients prescribed potentially inappropriate 
drugs
Generic name  Patients prescribed 
  each medicine (%)
Alprazolam 11.56
Lorazepam 11.1
Amitriptyline 9.1
Nifedipine 8.5
Promethazine 6.0
Oxybutynin 6.5
Fluoxetine 5.0
Oxybutynin 4.5
Cyclobenzaprine 4.0
Temazepam 3.5
Indomethacin 3.5
Amiodarone 3.5
Hydroxyzine 3.0
Diphenhydramine 3.0
Metaxalone 3.0
Naproxen 2.5
Chlorazepate 2.0
Diazepam 2.0
Ketorolac 1.5
Belladonna alkaloids  1.0
Perpheazine – amitriptyline  1.0
Piroxicam 1.0
Clidinium – Chlordiazepoxide  1.0
Chlorpheniramine 1.0
Oxaprozin 1.0
Meperidine 1.0
Chlordiazepoxide – amitriptyline  0.5
Chlordiazepoxide – amitriptyline  0.5
Diyclomine 0.5
Hyoscyamine 0.5
Nitrofurantoin 0.5
Oxazepam 0.5
Doxepin 0.5
Notes: Over the counter medications are not included; Barbiturates are not 
included as there is no knowledge whether or not the patient is taking them to 
control seizures.Clinical Interventions in Aging 2008:3(2) 387
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To illustrate the complexity of evaluating the prevalence 
of polypharmacy among older adults, we calculated the preva-
lence using two commonly cited deﬁ  nitions for polypharmacy 
to determine their validity and reliability. We found 13.7% 
more patients were identiﬁ  ed as recipients of ‘potentially 
inappropriate polypharmacy’ when the quantity-speciﬁ  c deﬁ  -
nition was used, ‘six or more concurrent medications.’ When 
a drug-speciﬁ  c deﬁ  nition was applied, we found that 15.7% 
were recipients of ‘potentially inappropriate polypharmacy.’ 
These disparate results call the validity and reliability into 
question. If our population is reﬂ  ective of our country’s geri-
atric population, this variance could represent approximately 
4.9 million patients based on data from the US Consensus 
Bureau (US Department of Commerce 2004).
According to several sources, including the American 
Psychiatric Association, the use of potentially inappropri-
ate drugs such as benzodiazepines is commonly associated 
with intellectual and cognitive impairment, psychomotor 
impairment, and increased risk for fall or motor vehicle 
accident (Bugonvic and Greenﬁ  eld 2004). Differentiating 
age-related, disease-related, and drug-related impairment 
can be challenging for any provider. A targeted approach 
to identify potentially inappropriate medications such as 
screening for particular high-risk drugs or contraindicated 
drugs may provide a higher sensitivity. Further evaluation 
to validate and identify the relative sensitivity of the deﬁ  ni-
tions applied to the database in this pilot project is needed. 
This effort will require more intensive review of individual 
patient proﬁ  les to identify contraindicated drugs, signiﬁ  cant 
drug/drug interactions, major drug/disease interactions, 
apparent drug associated morbidity or mortality, and unwar-
ranted duplications of therapy. If validated, one or both of 
these deﬁ  nitions could then be applied to claims data or man-
aged-care patient populations for comparison. Additionally, 
three unanswered questions emerged during our research 
that require additional discussion and exploration: Does 
pharmacy refer to medications or the actual location where 
clients pick up prescriptions? Is ‘polypharmacy’ a positive 
term meaning that multiple medications are used to treat dis-
ease effectively? Is it a negative term denoting inappropriate 
drug therapy? Or is it a neutral term simply referring to the 
concomitant use of more than one medications? Are the 
terms ‘polypharmacy’ and the phrase ‘inappropriate drug 
use’ mutually exclusive?
Our research supports the discontinuation of the use 
of the term ‘polypharmacy,’ agreeing with Preskorn and 
colleagues (2005) as well as Bushardt and Jones (2005). 
Preskorn (2005) recommends the alternative phrase ‘multiple 
medication use.’ However, Preskorn’s phrase has a neutral 
connotation because concomitant use of multiple drugs is 
often supported by evidence-based guidelines for various 
disease states (Preskorn 2005). Examples include treatment 
guidelines for heart failure developed by the American 
College of Cardiology and the American Heart Association 
as well as treatment guidelines for hypertension published 
in the seventh report of the Joint National Commission on 
Prevention, Detection, Evaluation and Treatment of High 
Blood Pressure (Chobanian et al 2003). Bushardt and Jones 
(2005) propose the alternative term ‘hyperpharmacotherapy’ 
because it offers a different connotation. According to the 
American Heritage Dictionary, ‘pharmacotherapy’ refers 
to the treatment of disease with the use of drugs. Thus, the 
addition of the preﬁ  x ‘hyper-’ to ‘pharmacotherapy’ implies 
an excessive use of drugs for treatment of disease.
Implications for practice
Because the elderly population has a higher prevalence 
of chronic diseases, multiple drug use is very common 
(Jorgensen et al 2001). An increase in the number of medica-
tions may pose a higher risk of hyperpharmacotherapy, and 
an assessment tool to ensure the safety of patients taking 
multiple drugs is needed (Feinberg and Simonson 2005). 
Many prescribers may feel overwhelmed when encounter-
ing an older adult who has been prescribed multiple drugs or 
whose drug therapy regimen is quite complex. The process 
for reviewing an individual patient’s drug therapy regimen 
for inappropriate polypharmacy, or ‘hyperpharmacotherapy,’ 
can be taught and supported by various clinical tools. Correc-
tive actions to reduce the burden of hyperpharmacotherapy 
for a patient may require a considerable amount of time 
Table 3 Hyperpharmacotherapy resource guides
Resource title Author Website Journal
1.     The 9 key questions to address 
polypharmacy in the elderly
2. Beer’s  criteria
3.   Principles of drug therapy for the elderly 
patient
Bushardt and Jones
Beers et al
Bressler and Bahl
http://jaapa.com/issues/j20050501/articles/
polypharm0505.htm
http://archinte.ama-assn.org/cgi/content/
full/163/22/2716
http://www.mayoclinicproceedings.com/
inside.asp?AID=761&UID=
JAAPA May 2005
Archives of Internal Medicine 
December 2003
Mayo Clinic Proceedings 2003Clinical Interventions in Aging 2008:3(2) 388
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and close monitoring as some drugs require tapering and 
monitoring. Additionally, pitfalls may be encountered if a 
provider attempts to make multiple changes to a regimen 
at a single point in time. Zarowitz (2006) has previously 
discussed the potential challenges involved with careless 
discontinuation of medications, including disease exacerba-
tion and hospitalization. Therefore, a more rational approach 
to drug discontinuation might involve tapering a single drug 
therapy at a time with careful monitoring for symptoms of 
withdrawal and disease exacerbation. Because the purpose 
of eliminating inappropriate polypharmacy includes enhanc-
ing quality of life for patients, it is important to pay careful 
attention to the discontinuation process.
Feinberg and Simonson (2005) suggest a comprehensive 
review of a patient’s drug regimen be performed annually, 
or more frequently if indicated. Several clinical tools have 
been published to help providers reduce hyperpharmaco-
therapy. Bushardt and Jones (2005) previously developed and 
published a series of nine questions for physician assistants 
to use to guide the drug therapy evaluation process (see 
Table 3). We have developed a comprehensive tool called 
the Hyperpharmacotherapy Assessment Tool (HAT), adapted 
from Bergman-Evans’ Medication Management Outcome 
Monitor (2006). It appears in Figure 1. Modiﬁ  cations were 
made to create a more concise tool as well as to include 
pertinent components not listed in the form developed by 
Hyperpharmacotherapy Assessment Tool (HAT)
Patient Name: 
Instructions: Evaluate drug proﬁ  le by using criteria below. The ﬁ  rst two criteria require numbers. Otherwise, use Y = Yes, N = No. When question is answered “Yes,” 
investigate ways to improve medication regimen. Drug discontinuation or tapering should generally be engaged with a single drug at the time. When choosing 
among multiple medications well suited for discontinuation, consider the underlying problem and review this series in descending order of priority: safety, toler-
ability, efﬁ  cacy, tolerability, price, and simplicity of use.  
Visit 1
Date:
Visit 2
Date:
Visit 3
Date:
Visit 4
Date:
Visit 5
Date:
Visit 6
Date:
GOAL I: Monitor Number of Medications
Total # of Prescription medications, OTC medications, vitamins or minerals, 
dietary supplements and herbs
Total # of Meds systemically or gastrointestinally absorbed
GOAL II: Decrease Inappropriate Drug Use
Has the disease state resolved that the drug(s) was originally prescribed for?
Is non-drug therapy an option?
Is there another drug more effective for the disease? 
Is there an equally effective, lower-cost drug available?
Is the patient taking another person’s medication?
Is the drug inappropriate for use in the elderly?
Are treatment goals unachieved?
GOAL III: Decrease Inappropriate Pharmacology
Are there any adverse effects to the medication(s)?
Is the patient using 2 or more drugs of the same chemical class or 
pharmacologic action? 
Is the patient taking combination pill(s) in which one of the medications is 
inappropriate?
Are there any drug-drug interactions? (OTC, herbal supplements, prescrip-
tion meds)
Are there any adverse drug-disease interactions?
Does the patient’s diet interfere with pharmacologic action?
Is there risk of addiction from the medication?
Is the patient at risk for accumulation from long-term use?
GOAL IV: Optimize dosing regimen
Is there a lower effective dose of the medication? 
Does the patient have any medications dosed more than 2 times per day?Clinical Interventions in Aging 2008:3(2) 389
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Does the patient have any problems with adherence to the drug regimen? 
(i.e. affording medications, problems reading labels, understanding instructions, 
identifying color of pills, breaking tablets, or using inhaler/syringes)?
Does the dosage need to be adjusted to reﬂ  ect age, renal, and liver status?
GOAL V: Organize sources of medication
Are there any additional medications prescribed by other healthcare providers 
that have not been identiﬁ  ed? 
Does the patient use multiple pharmacies?
Does the patient use mail-order pharmacy?
GOAL VI: Educate Patient
Is the patient or his/her caregiver unable to describe the purpose, side effects, 
instructions for the medication? 
Are the IADL and ADL becoming unstable?
COMMENTS
Visit 1
Visit 2
Visit 3
Visit 4
Visit 5
Visit 6
Figure 1 Hyperpharmacotherapy assessment tool (Adapted with permission from Bergman-Evans B. 2006 Evidence-based guideline: Improving medication management for 
older adult clients. J Gerontol Nurs, 32:6–14).
Bergman-Evans. Additional research by physician assistants 
can further reﬁ  ne this instrument.
Health professionals, particularly those in primary care, 
are well positioned to impact appropriate use of medication 
therapies for older adults. Mid-level practitioners such as 
physician assistants may be able to justify spending more 
time with patients in today’s healthcare system versus their 
physician supervisors. Additional time during a clinical 
interview could be used to conduct the medication review 
process.
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